Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-517 HPV vaccine safety and immunogenicity in healthy females
NCT00693615Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2000
- Primary completion
- Jan 2005
01
Overview
A Phase 2 trial of Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen in human papillomavirus infection, sponsored by GSK. Started Oct 2000; status: completed.
02
Drugs
Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00693615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693615.